FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      Gilead Completes Regulatory Approvals for Arcellx Acquisition

      Gilead Sciences, Inc. has announced that it has received all necessary regulatory approvals for its acquisition of Arcellx. This development marks a significant step forward in the company's plans to enhance its portfolio.

      In conjunction with the acquisition approval, Gilead has extended the expiration date of its tender offer to purchase all outstanding shares of Arcellx's common stock. The extension allows shareholders additional time to consider the offer as Gilead moves forward with the transaction.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud